false
Catalog
The Liver Meeting 2019
Controversies in Cirrhosis
Controversies in Cirrhosis
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In the video transcript, the speaker discusses key topics related to hepatic controversies and cirrhosis management. The talk covers the use of beta blockers in portal hypertension, prophylactic antibiotics for spontaneous bacterial peritonitis, herbal medication use, recent FDA warnings in hepatitis C treatment for cirrhotic individuals, and implications of acute on chronic liver failure. The discussion also includes considerations for liver transplantation, management of varices, and psychological support for patients. Questions from the audience address issues like managing patients with severe osteoporosis and esophageal varices, primary prophylaxis for spontaneous bacterial peritonitis, and reinitiating beta blockers post-SBP hospitalization. The speakers advocate for individualized patient care and multidisciplinary approaches in managing cirrhosis-related complications.
Asset Caption
Presenter: Renee S. Pozza
Keywords
hepatic controversies
cirrhosis management
beta blockers
portal hypertension
spontaneous bacterial peritonitis
FDA warnings
liver transplantation
×
Please select your language
1
English